Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

491.50

20-Dec-2024

Open
High
Low
Previous Close

508.10
515.35
487.10
509.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

102990
516.19
658.85
391.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

7,998.05
25.26
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

7,952.50
N/A
3.49

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.13
7.65
8.34

EBITDA CAGR (%)

10 Years
5 Years
3 Years

5.48
2.94
5.94

PAT CAGR (%)

10 Years
5 Years
3 Years

7.50
4.85
12.15

P:E (Median)

8 Years
5 Years
3 Years

20.72
21.97
25.54

P:BV (Average)

8 Years
5 Years
3 Years

2.93
2.96
2.90

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.05
14.85
16.27

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 18.7
P/E Ratio 27.31
Revenue 1908
EBITDA 338
Net Income 307
ROA 12.8
P/Bk Ratio 3.96
ROE 15.06
FCFF 154.95
FCFF Yield 1.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 505.10 479.70 5.29% 624.14 530.04 17.75% 454.23 431.20 5.34% 452.21 406.61 11.21%
Expenses 432.70 400.99 7.91% 482.45 410.03 17.66% 396.39 377.32 5.05% 370.31 360.09 2.84%
EBITDA 72.40 78.71 -8.02% 141.69 120.01 18.07% 57.84 53.88 7.35% 81.90 46.52 76.05%
EBIDTM 14.33% 16.41% 22.70% 22.64% 12.73% 12.49% 18.11% 11.44%
Other Income 34.68 27.39 26.62% 28.15 29.78 -5.47% 20.72 10.15 104.14% 25.33 18.76 35.02%
Interest 1.07 1.05 1.90% 1.29 1.04 24.04% 0.94 1.15 -18.26% 0.97 1.18 -17.80%
Depreciation 13.76 9.81 40.27% 11.00 9.59 14.70% 10.39 9.69 7.22% 9.93 9.81 1.22%
PBT 92.25 95.23 -3.13% 157.56 139.16 13.22% 67.22 53.19 26.38% 96.33 54.29 77.44%
Tax 18.28 23.19 -21.17% 42.57 30.61 39.07% 19.02 15.95 19.25% 17.96 14.86 20.86%
PAT 73.97 72.04 2.68% 114.99 108.55 5.93% 48.20 37.24 29.43% 78.38 39.43 98.78%
PATM 14.65% 15.02% 18.42% 20.48% 10.61% 8.64% 17.33% 9.70%
EPS 4.54 4.43 2.48% 7.06 6.67 5.85% 2.96 2.29 29.26% 4.81 2.42 98.76%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 513.85 486.37 5.65% 638.27 536.38 19.00% 462.03 434.80 6.26% 458.17 409.30 11.94%
Expenses 443.69 409.94 8.23% 491.65 414.37 18.65% 405.71 385.85 5.15% 374.38 360.06 3.98%
EBITDA 70.16 76.42 -8.19% 146.62 122.00 20.18% 56.33 48.95 15.08% 83.79 49.23 70.20%
EBIDTM 13.65% 15.71% 22.97% 22.75% 12.19% 11.26% 18.29% 12.03%
Other Income 34.70 27.24 27.39% 28.44 29.42 -3.33% 20.27 7.05 187.52% 24.71 18.41 34.22%
Interest 1.07 1.06 0.94% 1.30 1.05 23.81% 0.95 1.16 -18.10% 0.97 1.20 -19.17%
Depreciation 13.79 9.87 39.72% 11.02 9.63 14.43% 10.44 9.74 7.19% 9.97 9.86 1.12%
PBT 90.00 92.73 -2.94% 162.73 140.74 15.62% 65.21 45.11 44.56% 97.55 56.59 72.38%
Tax 17.96 22.94 -21.71% 43.70 30.93 41.29% 18.93 14.45 31.00% 18.37 15.88 15.68%
PAT 72.04 69.79 3.22% 119.04 109.81 8.41% 46.28 30.66 50.95% 79.17 40.71 94.47%
PATM 14.02% 14.35% 18.65% 20.47% 10.02% 7.05% 17.28% 9.95%
EPS 4.42 4.29 3.03% 7.31 6.62 10.42% 2.84 1.85 53.51% 4.87 2.46 97.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,035.68 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87 1,062.20 1,008.91 986.81 877.65 Net Sales Growth 10.18% 7.83% 16.99% 14.60% -0.42% 23.72% 1.29% 5.28% 2.24% 12.44% Cost Of Goods Sold 705.10 645.81 654.26 527.84 412.05 424.53 344.49 349.98 338.09 355.07 266.17 Gross Profit 1,330.58 1,270.37 1,122.77 991.12 913.40 906.56 731.39 712.22 670.81 631.74 611.48 GP Margin 65.36% 66.30% 63.18% 65.25% 68.91% 68.11% 67.98% 67.05% 66.49% 64.02% 69.67% Total Expenditure 1,681.85 1,577.73 1,523.84 1,272.12 1,001.12 1,047.51 855.83 843.10 766.96 759.85 680.92 Power & Fuel Cost - 37.38 34.08 28.89 27.06 27.38 24.60 21.98 21.52 23.12 20.15 % Of Sales - 1.95% 1.92% 1.90% 2.04% 2.06% 2.29% 2.07% 2.13% 2.34% 2.30% Employee Cost - 408.99 386.99 339.97 294.31 276.18 226.19 215.47 189.93 174.53 136.24 % Of Sales - 21.34% 21.78% 22.38% 22.20% 20.75% 21.02% 20.29% 18.83% 17.69% 15.52% Manufacturing Exp. - 170.27 154.77 128.20 77.94 68.76 62.19 58.70 49.34 36.39 97.19 % Of Sales - 8.89% 8.71% 8.44% 5.88% 5.17% 5.78% 5.53% 4.89% 3.69% 11.07% General & Admin Exp. - 103.67 99.60 69.39 54.95 57.18 58.56 60.53 52.70 49.55 41.11 % Of Sales - 5.41% 5.60% 4.57% 4.15% 4.30% 5.44% 5.70% 5.22% 5.02% 4.68% Selling & Distn. Exp. - 181.93 168.58 147.47 87.68 94.70 78.94 75.96 64.36 57.73 64.96 % Of Sales - 9.49% 9.49% 9.71% 6.62% 7.11% 7.34% 7.15% 6.38% 5.85% 7.40% Miscellaneous Exp. - 29.68 25.56 30.36 47.13 98.78 60.87 60.47 50.99 63.47 64.96 % Of Sales - 1.55% 1.44% 2.00% 3.56% 7.42% 5.66% 5.69% 5.05% 6.43% 6.28% EBITDA 353.83 338.46 253.19 246.85 324.33 283.58 220.04 219.10 241.95 226.96 196.73 EBITDA Margin 17.38% 17.66% 14.25% 16.25% 24.47% 21.30% 20.45% 20.63% 23.98% 23.00% 22.42% Other Income 108.88 103.22 55.29 78.73 97.15 82.66 54.80 51.25 49.65 39.98 44.38 Interest 4.27 4.00 4.04 3.05 3.40 3.41 1.43 1.40 1.41 1.40 1.75 Depreciation 45.08 39.73 38.76 37.08 37.62 37.36 33.14 35.04 34.52 33.61 38.50 PBT 413.36 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 200.85 Tax 97.83 90.78 64.72 65.82 85.96 78.68 64.76 65.59 62.72 63.03 54.94 Tax Rate 23.67% 22.81% 24.36% 23.06% 22.59% 24.18% 27.41% 28.04% 25.11% 27.18% 27.35% PAT 315.54 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 145.91 PAT before Minority Interest 315.54 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 145.91 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.50% 16.03% 11.31% 14.46% 22.22% 18.54% 15.94% 15.85% 18.54% 17.12% 16.63% PAT Growth 22.65% 52.84% -8.50% -25.42% 19.33% 43.86% 1.92% -10.03% 10.76% 15.76% EPS 19.38 18.87 12.34 13.49 18.09 15.16 10.54 10.34 11.49 10.37 8.96

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,072.32 1,942.94 1,783.75 1,527.92 1,333.20 1,344.19 1,090.70 1,075.07 1,013.87 994.32 889.31 Net Sales Growth 11.01% 8.92% 16.74% 14.61% -0.82% 23.24% 1.45% 6.04% 1.97% 11.81% Cost Of Goods Sold 718.14 656.15 655.79 530.21 414.07 425.72 345.14 352.08 339.05 357.93 272.91 Gross Profit 1,354.18 1,286.79 1,127.96 997.71 919.14 918.46 745.56 722.99 674.81 636.38 616.40 GP Margin 65.35% 66.23% 63.24% 65.30% 68.94% 68.33% 68.36% 67.25% 66.56% 64.00% 69.31% Total Expenditure 1,715.43 1,604.41 1,534.16 1,274.23 999.15 1,051.25 859.68 848.38 770.40 765.58 690.76 Power & Fuel Cost - 37.38 34.12 28.91 27.08 27.40 24.61 22.00 21.55 23.14 20.18 % Of Sales - 1.92% 1.91% 1.89% 2.03% 2.04% 2.26% 2.05% 2.13% 2.33% 2.27% Employee Cost - 413.40 390.90 343.33 296.29 277.48 225.57 216.67 191.08 175.76 137.58 % Of Sales - 21.28% 21.91% 22.47% 22.22% 20.64% 20.68% 20.15% 18.85% 17.68% 15.47% Manufacturing Exp. - 171.89 154.81 128.24 77.97 68.80 62.25 58.77 49.40 36.44 97.27 % Of Sales - 8.85% 8.68% 8.39% 5.85% 5.12% 5.71% 5.47% 4.87% 3.66% 10.94% General & Admin Exp. - 107.33 101.01 70.29 55.64 58.06 59.45 61.55 53.35 49.97 41.43 % Of Sales - 5.52% 5.66% 4.60% 4.17% 4.32% 5.45% 5.73% 5.26% 5.03% 4.66% Selling & Distn. Exp. - 187.19 171.01 147.96 87.74 94.70 78.92 75.96 64.36 57.73 64.96 % Of Sales - 9.63% 9.59% 9.68% 6.58% 7.05% 7.24% 7.07% 6.35% 5.81% 7.30% Miscellaneous Exp. - 31.06 26.53 25.28 40.37 99.07 63.73 61.35 51.61 64.61 64.96 % Of Sales - 1.60% 1.49% 1.65% 3.03% 7.37% 5.84% 5.71% 5.09% 6.50% 6.35% EBITDA 356.90 338.53 249.59 253.69 334.05 292.94 231.02 226.69 243.47 228.74 198.55 EBITDA Margin 17.22% 17.42% 13.99% 16.60% 25.06% 21.79% 21.18% 21.09% 24.01% 23.00% 22.33% Other Income 108.12 101.63 51.24 76.09 97.03 68.90 43.47 50.96 50.22 39.00 45.72 Interest 4.29 4.03 4.09 3.09 3.43 3.42 1.44 1.40 1.41 1.40 1.81 Depreciation 45.22 39.92 38.94 37.30 37.81 37.46 33.24 35.14 34.62 33.73 38.81 PBT 415.49 396.22 257.80 289.39 389.83 320.97 239.80 241.11 257.65 232.62 203.65 Tax 98.96 91.16 63.98 73.23 86.53 80.08 66.85 67.12 63.30 63.48 55.51 Tax Rate 23.82% 23.01% 24.82% 25.30% 22.32% 24.95% 28.01% 27.84% 25.14% 27.29% 27.26% PAT 316.53 305.22 194.04 216.40 301.33 240.89 171.85 173.99 188.47 169.14 148.15 PAT before Minority Interest 316.59 305.06 193.83 216.16 301.18 240.89 171.85 173.99 188.47 169.14 148.15 Minority Interest 0.06 0.16 0.21 0.24 0.15 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.27% 15.71% 10.88% 14.16% 22.60% 17.92% 15.76% 16.18% 18.59% 17.01% 16.66% PAT Growth 26.12% 57.30% -10.33% -28.19% 25.09% 40.17% -1.23% -7.68% 11.43% 14.17% EPS 19.44 18.75 11.92 13.29 18.51 14.80 10.56 10.69 11.58 10.39 9.10

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,097.20 1,980.74 1,948.69 1,722.17 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 929.59 Share Capital 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 17.86 Total Reserves 2,080.92 1,964.15 1,931.80 1,705.28 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 911.72 Non-Current Liabilities 597.62 462.65 384.43 299.56 314.62 229.17 211.41 216.67 19.93 24.24 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.03 0.11 0.21 0.34 0.49 0.60 0.69 0.79 0.90 Long Term Provisions 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 0.56 Current Liabilities 612.23 728.67 688.60 620.07 562.37 494.21 476.08 387.41 162.11 185.73 Trade Payables 184.63 178.48 136.26 76.66 117.54 77.20 96.95 74.66 82.30 86.26 Other Current Liabilities 99.96 95.93 85.87 76.83 79.53 60.88 66.76 63.10 49.58 36.28 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 327.64 454.27 466.47 466.59 365.29 356.13 312.37 249.65 30.24 63.19 Total Liabilities 3,307.05 3,172.06 3,021.72 2,641.80 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 1,139.56 Net Block 676.39 694.93 700.97 685.02 669.77 678.47 669.75 674.50 670.89 381.37 Gross Block 985.51 971.79 942.26 890.57 840.73 813.68 772.29 742.10 704.26 613.76 Accumulated Depreciation 309.12 276.86 241.29 205.56 170.96 135.21 102.53 67.61 33.36 232.39 Non Current Assets 1,947.92 1,730.32 1,615.15 1,299.40 1,177.74 1,109.97 973.09 954.70 738.52 640.95 Capital Work in Progress 260.88 197.84 104.36 19.21 23.85 12.38 12.84 6.32 19.92 28.80 Non Current Investment 399.70 348.71 384.95 265.58 162.53 179.33 74.40 54.82 39.76 223.12 Long Term Loans & Adv. 609.50 487.39 424.04 326.63 320.83 239.08 215.28 218.46 7.70 6.76 Other Non Current Assets 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 0.90 Current Assets 1,355.13 1,439.89 1,406.56 1,342.39 1,241.06 1,046.45 976.80 913.10 520.05 498.17 Current Investments 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 272.49 Inventories 383.47 323.34 303.63 213.27 209.49 172.73 159.65 136.22 130.24 121.53 Sundry Debtors 114.61 121.25 79.71 107.80 124.19 83.52 76.71 77.46 64.03 60.70 Cash & Bank 21.65 20.80 32.06 26.86 28.96 15.70 21.12 23.02 13.50 11.66 Other Current Assets 385.38 12.26 11.46 19.54 376.17 368.57 322.16 239.86 26.88 31.79 Short Term Loans & Adv. 365.27 504.94 478.94 450.07 349.81 357.56 311.65 230.44 20.30 16.15 Net Current Assets 742.91 711.22 717.96 722.33 678.69 552.24 500.72 525.69 357.93 312.44 Total Assets 3,303.05 3,170.21 3,021.71 2,641.79 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57 1,139.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,097.17 1,982.05 1,956.79 1,734.13 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 936.38 Share Capital 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 17.86 Total Reserves 2,080.89 1,965.46 1,939.91 1,717.25 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 918.52 Non-Current Liabilities 604.16 468.64 391.17 299.63 314.62 229.17 211.41 216.67 19.93 24.06 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.25 0.56 0.65 0.72 0.34 0.49 0.60 0.69 0.79 0.90 Long Term Provisions 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 0.56 Current Liabilities 615.18 729.56 690.40 621.79 564.62 497.43 480.07 389.40 163.42 187.97 Trade Payables 186.03 178.49 136.94 77.28 117.86 77.61 97.32 75.10 82.59 87.17 Other Current Liabilities 101.50 96.59 86.44 77.36 80.06 61.67 68.78 64.11 50.16 36.61 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 Short Term Provisions 327.64 454.48 467.01 467.15 366.69 358.15 313.97 250.19 30.67 63.19 Total Liabilities 3,316.51 3,179.61 3,037.93 2,655.38 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 1,148.41 Net Block 680.26 698.92 705.06 689.15 673.50 682.19 673.64 678.05 675.16 393.04 Gross Block 987.18 973.27 949.42 897.55 844.97 817.80 776.49 745.84 708.81 629.67 Accumulated Depreciation 306.92 274.35 244.36 208.40 171.47 135.61 102.84 67.79 33.65 236.62 Non Current Assets 1,945.46 1,734.70 1,619.50 1,303.33 1,181.25 1,113.46 976.64 957.93 742.46 646.27 Capital Work in Progress 261.48 198.44 104.82 19.21 23.85 12.38 12.84 6.32 19.92 28.80 Non Current Investment 392.76 348.49 384.73 265.36 162.31 179.11 74.07 54.49 39.43 216.72 Long Term Loans & Adv. 609.51 487.41 424.05 326.65 320.83 239.08 215.28 218.46 7.70 6.37 Other Non Current Assets 1.45 1.45 0.84 2.96 0.75 0.71 0.81 0.60 0.25 1.33 Current Assets 1,367.05 1,443.06 1,418.43 1,352.05 1,245.41 1,058.38 990.94 918.34 523.36 502.13 Current Investments 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 272.49 Inventories 388.89 328.54 304.70 214.92 209.96 173.79 160.49 137.16 130.91 123.22 Sundry Debtors 117.38 122.65 82.17 110.54 123.74 87.53 81.66 76.06 61.94 61.04 Cash & Bank 26.29 24.94 38.66 31.58 32.32 21.26 29.30 28.47 18.02 14.95 Other Current Assets 384.46 9.94 11.70 19.76 377.15 369.88 322.33 240.12 27.10 30.44 Short Term Loans & Adv. 365.27 499.69 480.43 450.41 350.34 358.56 311.65 230.44 20.36 14.77 Net Current Assets 751.87 713.50 728.03 730.26 680.79 560.94 510.87 528.94 359.94 314.16 Total Assets 3,312.51 3,177.76 3,037.93 2,655.38 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82 1,148.40

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 220.81 164.72 162.38 209.84 239.04 103.79 147.76 153.09 171.09 126.56 PBT 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 200.85 Adjustment -52.32 1.00 -23.59 -40.75 8.36 -13.54 -1.86 -11.07 0.24 -1.54 Changes in Working Capital -21.91 -25.11 -21.17 -36.05 -11.00 -51.34 -16.54 -18.76 -5.75 -10.77 Cash after chg. in Working capital 323.71 241.58 240.69 303.65 322.82 175.38 215.50 225.84 226.42 188.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.90 -76.86 -78.31 -93.81 -83.78 -71.60 -67.75 -69.78 -55.33 -61.98 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 0.00 Cash From Investing Activity -17.76 3.62 -147.42 -84.18 -84.80 -109.30 20.15 -143.55 -72.76 -88.89 Net Fixed Assets -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 Net Investments -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 -72.39 Others 102.73 46.91 84.72 86.67 33.23 45.33 37.07 46.87 -161.58 153.39 Cash from Financing Activity -202.03 -179.83 -9.70 -126.49 -142.00 -0.07 -169.43 0.35 -96.98 -47.47 Net Cash Inflow / Outflow 1.02 -11.48 5.26 -0.83 12.24 -5.58 -1.53 9.90 1.36 -9.80 Opening Cash & Equivalents 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 10.58 21.08 Closing Cash & Equivalent 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 11.28

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 220.77 154.91 161.65 207.08 250.38 112.43 149.84 154.49 174.30 127.64 PBT 396.22 257.80 289.39 389.85 319.95 237.75 240.63 257.71 232.15 203.65 Adjustment -51.18 4.32 -26.48 -48.34 22.58 -0.21 0.39 -10.88 2.41 -1.40 Changes in Working Capital -20.35 -29.91 -21.72 -39.42 -7.77 -51.05 -23.24 -19.23 -4.54 -11.78 Cash after chg. in Working capital 324.69 232.21 241.19 302.09 334.77 186.49 217.78 227.60 230.02 190.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -103.92 -77.30 -79.54 -95.01 -84.39 -74.06 -67.94 -70.14 -55.73 -62.84 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 0.00 Cash From Investing Activity -17.08 11.13 -144.57 -77.15 -98.35 -120.33 20.11 -143.55 -73.05 -88.57 Net Fixed Assets -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 -169.89 Net Investments -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 -72.39 Others 103.41 54.42 87.57 93.70 19.68 34.30 37.03 46.87 -161.87 153.71 Cash from Financing Activity -202.16 -179.95 -9.84 -129.35 -142.00 -0.07 -169.43 0.35 -96.98 -47.76 Net Cash Inflow / Outflow 1.53 -13.90 7.25 0.58 10.03 -7.96 0.52 11.29 4.27 -8.69 Opening Cash & Equivalents 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 12.17 23.26 Closing Cash & Equivalent 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 14.56

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 128.81 119.39 115.44 102.02 90.18 82.16 72.38 71.06 60.53 52.22 ROA 9.48% 6.49% 7.76% 11.64% 10.79% 8.35% 8.82% 11.97% 14.09% 13.24% ROE 15.06% 10.23% 11.97% 18.04% 16.59% 12.73% 13.33% 15.99% 16.85% 16.50% ROCE 19.71% 13.70% 15.66% 23.43% 22.06% 17.63% 18.62% 21.45% 23.25% 22.89% Fixed Asset Turnover 2.02 1.91 1.71 1.57 1.65 1.39 1.41 1.45 1.53 1.68 Receivable days 21.82 20.01 21.87 31.18 27.76 26.53 26.29 24.69 22.54 24.73 Inventory Days 65.39 62.44 60.30 56.83 51.08 55.04 50.45 46.49 45.50 45.20 Payable days 102.61 87.79 73.61 86.01 38.13 40.20 41.31 40.79 44.71 48.03 Cash Conversion Cycle -15.40 -5.34 8.56 2.00 40.71 41.37 35.43 30.39 23.32 21.90 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 100.49 66.79 94.65 112.82 96.31 166.02 167.77 178.52 167.05 115.57

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 128.81 119.47 115.92 102.73 90.51 82.86 73.17 71.42 60.87 52.62 ROA 9.39% 6.23% 7.59% 11.85% 10.48% 8.30% 9.05% 12.00% 14.01% 13.34% ROE 14.96% 9.84% 11.71% 18.36% 16.10% 12.63% 13.67% 16.02% 16.76% 16.64% ROCE 19.62% 13.27% 15.78% 23.74% 21.63% 17.64% 19.04% 21.51% 23.15% 23.02% Fixed Asset Turnover 2.04 1.91 1.70 1.57 1.66 1.41 1.42 1.44 1.52 1.65 Receivable days 21.91 20.32 22.35 31.31 27.96 27.55 26.58 23.96 22.06 24.19 Inventory Days 65.48 62.83 60.27 56.79 50.80 54.43 50.15 46.55 45.58 45.45 Payable days 101.39 87.78 73.73 86.01 38.19 40.35 41.32 40.83 44.81 47.89 Cash Conversion Cycle -14.00 -4.62 8.89 2.09 40.57 41.62 35.41 29.68 22.84 21.74 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 99.22 64.07 94.67 113.90 94.95 166.95 172.62 179.60 167.11 113.30

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

icici prudential smallcap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

FDC gets final nod for Cefixime 400 mg Tablets
18th Dec 2024, 17:08 PM

The company has received final approval from U.S. Food and Drug Administration
Read More
FDC recalling 1,55,232 bottles of Timolol Maleate ophthalmic solution in US market
18th Nov 2024, 11:00 AM

The company initiated the Class II recall on October 29, 2024
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback